Crossmark

Contemporary outcomes of a DCB-based strategy with selective stent implantation for femoropopliteal artery lesions: results from the REAL-LEAD registry

Crossref DOI link: https://doi.org/10.1186/s42155-026-00744-1

Published Online: 2026-07-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fujita, Takafumi https://orcid.org/0009-0007-2059-0166
Sugihara, Makoto

Mine, Kaori

Ogata, Kenji

Kobata, Shinya

Furukawa, Shotaro

Yoshiga, Takumi

Ishizaki, Yuta

Oe, Kensuke

Kakazu, Atsushi

Yanari, Ryosuke

Kyuragi, Ryoichi

Furukawa, Shoichiro

Kusumoto, Saburo

Akashi, Ryohei

Karashima, Eiji

Doi, Hideki

Miura, Shin-ichiro
License Information

Text and Data Mining valid from 2026-07-30

Version of Record valid from 2026-07-30
More Information

Article History

Received: 30 March 2026

Accepted: 22 July 2026

First Online: 30 July 2026

Declarations

Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki. The Institutional Ethics Committee of the Fukuoka University School of Medicine approved this study (approval number: U21-09–002). Approval was granted on September 9, 2021. The Institutional Review Board (IRB) at Fukuoka University School of Medicine acted as the central IRB, and its review was accepted by the IRBs of all of the participating institutions (Ref. U21-09–002). The central IRB determined that this research involved minimal risk and approved a waiver for informed consent.

Consent for publication: Not applicable.

Competing interest: The authors declare no potential conflicts of interest with respect to the research, authorship, and publication of this article.

Document is current

Any future updates will be listed below